Over the last 7 days, the Clinical Research and Equipment industry has risen 3.3%, driven by gains from Oxford Nanopore Technologies of 0.7%. In the same time, Diaceutics was down 5.6%. However, the industry is down 14% over the past year. As for the next few years, earnings are expected to grow by 30% per annum.
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 13 Jun 2025 | UK£1.6b | UK£319.3m | -UK£190,663,434.70 | 7.3x | -8.3x | 4.9x |
Sun, 11 May 2025 | UK£1.7b | UK£313.2m | -UK£192,933,253.70 | 11.2x | -8.7x | 5.4x |
Tue, 08 Apr 2025 | UK£1.4b | UK£316.2m | -UK£187,033,235.65 | 5.6x | -7.3x | 4.3x |
Thu, 06 Mar 2025 | UK£1.4b | UK£321.2m | -UK£182,218,593.52 | 6.8x | -7.9x | 4.5x |
Sat, 01 Feb 2025 | UK£2.1b | UK£306.9m | -UK£195,557,155.92 | 7.5x | -10.6x | 6.7x |
Mon, 30 Dec 2024 | UK£1.8b | UK£306.6m | -UK£195,250,541.04 | 7.6x | -9.4x | 6x |
Wed, 27 Nov 2024 | UK£1.9b | UK£306.7m | -UK£193,121,091.20 | 7.7x | -9.6x | 6x |
Fri, 25 Oct 2024 | UK£2.0b | UK£304.7m | -UK£192,536,544.40 | 10.9x | -10.5x | 6.6x |
Sun, 22 Sep 2024 | UK£2.2b | UK£303.8m | -UK£191,679,415.50 | 11.5x | -11.5x | 7.3x |
Tue, 20 Aug 2024 | UK£1.9b | UK£296.1m | -UK£188,672,625.30 | 12.3x | -10x | 6.4x |
Thu, 18 Jul 2024 | UK£1.7b | UK£295.0m | -UK£189,507,675.57 | 12.3x | -9.1x | 5.8x |
Sat, 15 Jun 2024 | UK£1.6b | UK£295.8m | -UK£189,931,418.67 | 11.6x | -8.2x | 5.3x |
Mon, 13 May 2024 | UK£1.7b | UK£295.1m | -UK£187,865,864.75 | 6797.2x | -8.9x | 5.6x |
Wed, 10 Apr 2024 | UK£1.7b | UK£317.2m | -UK£178,028,849.39 | 12.2x | -9.4x | 5.3x |
Fri, 08 Mar 2024 | UK£1.9b | UK£292.9m | -UK£212,421,186.86 | 7034.5x | -8.8x | 6.4x |
Sun, 04 Feb 2024 | UK£2.8b | UK£450.4m | -UK£176,742,955.00 | 69.8x | -16x | 6.3x |
Tue, 02 Jan 2024 | UK£3.2b | UK£449.9m | -UK£173,922,769.00 | 56.2x | -18.3x | 7.1x |
Thu, 30 Nov 2023 | UK£3.1b | UK£455.2m | -UK£168,326,347.00 | 50.5x | -18.2x | 6.7x |
Sat, 28 Oct 2023 | UK£3.0b | UK£458.8m | -UK£165,732,145.00 | 46.7x | -18x | 6.5x |
Mon, 25 Sep 2023 | UK£3.1b | UK£447.9m | -UK£167,427,280.00 | 67.5x | -18.3x | 6.8x |
Wed, 23 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,492,634.00 | 70.6x | -24.7x | 6.6x |
Fri, 21 Jul 2023 | UK£3.4b | UK£476.3m | -UK£124,508,381.00 | 69.6x | -27.5x | 7.2x |
Sun, 18 Jun 2023 | UK£3.1b | UK£476.3m | -UK£124,569,758.00 | 64.4x | -24.5x | 6.4x |
Tue, 16 May 2023 | UK£3.2b | UK£477.7m | -UK£122,669,906.00 | 36.3x | -25.7x | 6.6x |
Thu, 13 Apr 2023 | UK£3.0b | UK£458.6m | -UK£118,812,527.00 | 32.5x | -25.1x | 6.5x |
Sat, 11 Mar 2023 | UK£2.9b | UK£443.7m | -UK£183,261,487.00 | 42.3x | -16x | 6.6x |
Mon, 06 Feb 2023 | UK£3.6b | UK£443.7m | -UK£183,109,070.00 | 48.7x | -19.7x | 8.1x |
Wed, 04 Jan 2023 | UK£3.5b | UK£443.9m | -UK£183,165,322.00 | 50.2x | -19x | 7.8x |
Fri, 02 Dec 2022 | UK£3.6b | UK£446.3m | -UK£178,828,714.00 | 51.8x | -20.2x | 8.1x |
Sun, 30 Oct 2022 | UK£3.7b | UK£448.1m | -UK£175,999,972.00 | 46.1x | -21.1x | 8.3x |
Tue, 27 Sep 2022 | UK£3.3b | UK£435.0m | -UK£177,474,663.00 | 45.3x | -18.8x | 7.7x |
Thu, 25 Aug 2022 | UK£3.7b | UK£369.6m | -UK£189,836,281.00 | 46.6x | -19.4x | 9.9x |
Sat, 23 Jul 2022 | UK£3.8b | UK£366.9m | -UK£188,215,859.00 | 39.3x | -20.2x | 10.4x |
Mon, 20 Jun 2022 | UK£3.8b | UK£363.9m | -UK£189,545,348.00 | 37.7x | -20x | 10.4x |
-20x
How does U.K. Clinical Research and Equipment compare with similar industries?
GB Market | 0.84% | |
Healthcare | 2.23% | |
Life Sciences | 0.68% | |
Clinical Research and Equipment | 0.68% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ONT Oxford Nanopore Technologies | UK£1.22 | 0.7% +UK£8.6m | 24.0% | PS6.4x | |
HVO hVIVO | UK£0.12 | 7.0% +UK£5.1m | -58.5% | PE7.3x | |
MXCT MaxCyte | UK£1.69 | 1.2% +UK£2.1m | -55.7% | PS6.5x | |
IXI IXICO | UK£0.12 | 8.9% +UK£926.7k | 78.2% | PS1.8x | |
FAB Fusion Antibodies | UK£0.067 | 4.7% +UK£341.0k | 92.8% | PS4.2x |